Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer
Status:
Completed
Trial end date:
2017-09-05
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the efficacy of
monosialotetrahexosylganglioside (GM1) for preventing oxaliplatin induced neurotoxicity in
colorectal cancer patients who received oxaliplatin-based adjuvant chemotherapy.